Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alemany

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Gene Therapy|May 30, 2008
Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replicationS Guedan, A Gros, M Cascallo, et al.
Cancer Gene Therapy|July 31, 2010
Osteosarcoma cells as carriers to allow antitumor activity of canine oncolytic adenovirus in the presence of neutralizing antibodiesF Alcayaga-Miranda, M Cascallo, J J Rojas, et al.
Annals of the New York Academy of Sciences|July 12, 1995
Chronic imidazoline drug treatment increases the immunoreactivity of glial fibrillary acidic protein in rat brain. LSL 60101 as a novel and selective ligand for I2-imidazoline receptorsJ A García-Sevilla, R Alemany, G Olmos, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo|August 1, 1972
[Study of the elimination of uropepsinogen in rats subjected to isolation with and without stress]F Sánchez de la Cuesta, R Monfort, J R Alemany, et al.
Life Sciences|June 8, 2001
Sphingosine kinase-mediated calcium signaling by muscarinic acetylcholine receptorsC J van Koppen, D Meyer zu Heringdorf, R Alemany, et al.
Gene Therapy|July 22, 2011
Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGDJ J Rojas, M Gimenez-Alejandre, R Gil-Hoyos, et al.
The Journal of Biological Chemistry|February 6, 1999
Formyl peptide receptor signaling in HL-60 cells through sphingosine kinaseR Alemany, D Meyer zu Heringdorf, C J van Koppen, et al.
Cancer Research|August 28, 2001
Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion moleculeA Hemminki, I Dmitriev, B Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potencyK Suzuki, J Fueyo, V Krasnykh, et al.
Cancer Gene Therapy|January 18, 2014
The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent modelC Puig-Saus, E Laborda, A Rodríguez-García, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Gene Therapy|May 30, 2008
Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replicationS Guedan, A Gros, M Cascallo, et al.
Cancer Gene Therapy|July 31, 2010
Osteosarcoma cells as carriers to allow antitumor activity of canine oncolytic adenovirus in the presence of neutralizing antibodiesF Alcayaga-Miranda, M Cascallo, J J Rojas, et al.
Annals of the New York Academy of Sciences|July 12, 1995
Chronic imidazoline drug treatment increases the immunoreactivity of glial fibrillary acidic protein in rat brain. LSL 60101 as a novel and selective ligand for I2-imidazoline receptorsJ A García-Sevilla, R Alemany, G Olmos, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo|August 1, 1972
[Study of the elimination of uropepsinogen in rats subjected to isolation with and without stress]F Sánchez de la Cuesta, R Monfort, J R Alemany, et al.
Life Sciences|June 8, 2001
Sphingosine kinase-mediated calcium signaling by muscarinic acetylcholine receptorsC J van Koppen, D Meyer zu Heringdorf, R Alemany, et al.
Gene Therapy|July 22, 2011
Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGDJ J Rojas, M Gimenez-Alejandre, R Gil-Hoyos, et al.
The Journal of Biological Chemistry|February 6, 1999
Formyl peptide receptor signaling in HL-60 cells through sphingosine kinaseR Alemany, D Meyer zu Heringdorf, C J van Koppen, et al.
Cancer Research|August 28, 2001
Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion moleculeA Hemminki, I Dmitriev, B Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potencyK Suzuki, J Fueyo, V Krasnykh, et al.
Cancer Gene Therapy|January 18, 2014
The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent modelC Puig-Saus, E Laborda, A Rodríguez-García, et al.
Pageof 8